Finally, recent studies have established that cancer cells utilize Arf6-dependent mechanisms to generate and release plasma-membrane derived microvesicles containing proteases and other factors that can promote invasion and tumor progression (Muralidharan-Chari et al., 2009, 2012). This evidence concerns the gene ARF6 and cancer.